Source: Eur Respir J 2016; 48: 242-244
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nanda, Catriona Ruth, Singapuri, Amisha, Soares, Marcia, Monteiro, William, Siddiqui, Salman, Gonem, Sherif. Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma. Eur Respir J 2016; 48: 242-244

Member's Comments

No comment yet.

Related content which might interest you: The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 366s Year: 2007 Relationship between exhaled nitric oxide and bronchial hyperreactivity in adult with asthma Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009 Exhaled nitric oxide and bronchial hyperresponsiveness in steroid-naive patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Evaluation of exhaled nitric oxide and sputum eosinophils as markers of inflammation in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003 The relationship between exhaled nitric oxide, bronchial hyperresponsiveness and exercise-induced bronchospasm in Japanese children with asthma Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010 Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity Source: Eur Respir J 2015; 45: 98-106 Year: 2015 Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004 Applications of exhaled and nasal nitric oxide in airway diseases Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002 Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Exhaled nitric oxide as predictor of bronchial hyperresponsiveness to methacholine in subjects with respiratory symptoms Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Increased exhaled nitric oxide in nonatopic asthma Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air Year: 2003 Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007